Steve Valiquette
Stock Analyst at Barclays
(1.46)
# 3,491
Out of 4,996 analysts
158
Total ratings
45.87%
Success rate
-3.57%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BKD Brookdale Senior Living | Maintains: Equal-Weight | $7.5 → $8 | $8.34 | -4.08% | 5 | Aug 7, 2025 | |
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $8.16 | +47.06% | 13 | Oct 31, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $760.55 | -19.01% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $4.04 | +122.77% | 7 | Mar 1, 2024 | |
| HOUS Anywhere Real Estate | Maintains: Underweight | $4.5 → $5 | $10.44 | -52.11% | 3 | Feb 20, 2024 | |
| MPW Medical Properties Trust | Maintains: Overweight | $12 → $10 | $4.92 | +103.25% | 5 | Aug 22, 2023 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $17.86 | +34.38% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $75.77 | +13.50% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $34.86 | +143.83% | 6 | Jul 31, 2023 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $275 → $300 | $419.08 | -28.41% | 4 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $35 → $34 | $36.61 | -7.13% | 3 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $105 | $202.00 | -48.02% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $69.00 | -20.29% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $18.83 | -30.96% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $200.85 | -29.30% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $27.61 | -81.89% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $126.70 | -55.01% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $174.90 | -53.12% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $18.94 | -4.96% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $41.84 | -25.91% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $191.98 | +95.33% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $34.80 | -45.40% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $254.95 | +123.57% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $153.71 | -58.36% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $286.17 | +8.33% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $344.08 | +64.21% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $4.53 | +1,555.63% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $4.79 | +296.66% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $3.18 | +214.47% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $42 → $34 | $27.81 | +22.26% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $8.75 | +128.57% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $99.08 | +162.41% | 1 | Feb 19, 2021 |
Brookdale Senior Living
Aug 7, 2025
Maintains: Equal-Weight
Price Target: $7.5 → $8
Current: $8.34
Upside: -4.08%
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $8.16
Upside: +47.06%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $760.55
Upside: -19.01%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $4.04
Upside: +122.77%
Anywhere Real Estate
Feb 20, 2024
Maintains: Underweight
Price Target: $4.5 → $5
Current: $10.44
Upside: -52.11%
Medical Properties Trust
Aug 22, 2023
Maintains: Overweight
Price Target: $12 → $10
Current: $4.92
Upside: +103.25%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $17.86
Upside: +34.38%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $75.77
Upside: +13.50%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $34.86
Upside: +143.83%
HCA Healthcare
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $419.08
Upside: -28.41%
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $36.61
Upside: -7.13%
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $202.00
Upside: -48.02%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $69.00
Upside: -20.29%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $18.83
Upside: -30.96%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $200.85
Upside: -29.30%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $27.61
Upside: -81.89%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $126.70
Upside: -55.01%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $174.90
Upside: -53.12%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $18.94
Upside: -4.96%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $41.84
Upside: -25.91%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $191.98
Upside: +95.33%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $34.80
Upside: -45.40%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $254.95
Upside: +123.57%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $153.71
Upside: -58.36%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $286.17
Upside: +8.33%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $344.08
Upside: +64.21%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $4.53
Upside: +1,555.63%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $4.79
Upside: +296.66%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $3.18
Upside: +214.47%
May 28, 2021
Downgrades: Underweight
Price Target: $42 → $34
Current: $27.81
Upside: +22.26%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $8.75
Upside: +128.57%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $99.08
Upside: +162.41%